hemotune raises CHF 5.1 million Series A funding


hemotune AG, currently incubated at Wyss Zurich, today announced the closing of a CHF 5.1 million Series A to advance the development of HemoSystem, a breakthrough blood purification platform based on nanoengineered magnetic beads. Despite the corona crisis, hemotune managed to build a very strong consortium led by OCCIDENT with participation of the Korean medical device company Green Cross Medical Science Corp. (GCMS), and Zürcher Kantonalbank.


Click on the link below to read the full press release:

hemotune Press Release Funding Round

Featured Posts
Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • Google+ Social Icon

© 2020 by hemotune

  • Black LinkedIn Icon
  • Black Twitter Icon
  • YouTube

created by wyssraumdesign